For Immediate Release:
August 23, 2023
Contact:
Tasgola Bruner 202-483-7382
Durham, N.C. – PETA Science Consortium International e.V. is sending a North Carolina Central University (NCCU) professor to the 12th World Congress on Alternatives and Animal Use in the Life Sciences in Canada this month to share and learn about efforts to replace the use of animals in laboratories.
Dr. Antonio (Tony) Baines is the winner of the Science Consortium’s travel award to attend the conference, which is held every three years and will take place August 27 to 31 this year in Niagara Falls, Canada. The event will focus on “3Rs Over the Edge: Regulatory Acceptance and Next-Gen Education.”
Dr. Baines was selected from a global pool of highly skilled applicants. He is an associate professor in the Department of Biological and Biomedical Sciences at NCCU. He’s also an adjunct associate professor in the Department of Pharmacology and a member of the Curriculum in Toxicology & Environmental Medicine at the University of North Carolina at Chapel Hill.
“Dr. Baines proved to be a standout based on his excellence in research and dedication to helping students learn about human-relevant 21st century methods that can be used in biomedical research,” says Science Consortium President Dr. Amy Clippinger. “We look forward to his contributions at the 12th World Congress.”
The Science Consortium routinely recognizes and awards scientists who embrace human-relevant, animal-free testing methods. The awards include travel grants as well as cutting-edge technology, such as laboratory equipment and three-dimensional human tissue models to replace the use of animals in tests.
At this year’s World Congress, the Science Consortium will chair sessions and deliver oral and poster presentations on a variety of topics, such as how to evaluate confidence in new methods in order to accelerate the uptake of relevant, reliable, non-animal test methods. It will also present on modern, animal-free tools to assess the risks of chemicals on the environment and on using novel approaches to test chemicals for their potential to cause cancer or eye irritation.
For more information, please visit ThePSCI.eu.